- Previous Close
0.0000 - Open
0.0005 - Bid 0.2001 x --
- Ask 0.3000 x --
- Day's Range
0.0005 - 0.0005 - 52 Week Range
0.0001 - 2.1600 - Volume
12,624 - Avg. Volume
1,121 - Market Cap (intraday)
352 - Beta (5Y Monthly) -40.48
- PE Ratio (TTM)
-- - EPS (TTM)
-7.6400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
www.lucyscientific.com2
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: LSDIF
View MorePerformance Overview: LSDIF
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LSDIF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LSDIF
View MoreValuation Measures
Market Cap
8.82k
Enterprise Value
2.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.53
Price/Book (mrq)
0.11
Enterprise Value/Revenue
120.19
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-99.35%
Return on Equity (ttm)
--
Revenue (ttm)
16.73k
Net Income Avi to Common (ttm)
-10.23M
Diluted EPS (ttm)
-7.6400
Balance Sheet and Cash Flow
Total Cash (mrq)
211.12k
Total Debt/Equity (mrq)
85.69%
Levered Free Cash Flow (ttm)
-6.54M